Apo(a) isoforms predict risk for coronary heart disease - A study in six populations
Sandholzer, C. Saha, N. Kark, J.D. Rees, A. Jaross, W. Dieplinger, H. Hoppichler, F. Boerwinkle, E. Utermann, G.
Sandholzer, C.
Kark, J.D.
Rees, A.
Jaross, W.
Dieplinger, H.
Hoppichler, F.
Boerwinkle, E.
Utermann, G.
Citations
Altmetric:
Alternative Title
Abstract
Elevated concentrations of lipoprotein(a) (Lp[a]) in plasma are associated with premature coronary heart disease (CHD). Lp(a) levels are largely determined by alleles at the hypervariable apolipoprotein(a) (apo[a]) gene locus, but other genetic and environmental factors as well as diseases also affect plasma Lp(a) concentrations. It is therefore unclear whether Lp(a) is a primary genetic risk factor or whether Lp(a) levels are elevated secondary to disease in CHD patients. We have analyzed apo(a) phenotypes that represent a stable genetic trait in subjects with CHD and control subjects from different populations representing a variety of ethnic groups (Tyrol, Germany, Wales, Israel, Singapore Chinese, and Singapore Indian). Despite differences in sampling design and disease definition in this multipopulation case-control study, those apo(a) isoforms associated with high Lp(a) plasma concentrations (B, S1, and S2) were more frequent in the CHD patients in each ethnic group. These differences were significant in three of the studied populations and highly significant (p
Keywords
Apolipoprotein(a) gene, Coronary risk, Lipoprotein(a), Population genetics
Source Title
Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher
Series/Report No.
Collections
Rights
Date
1992
DOI
Type
Article